1. Academic Validation
  2. The role of JAK/STAT signaling pathway and its inhibitors in diseases

The role of JAK/STAT signaling pathway and its inhibitors in diseases

  • Int Immunopharmacol. 2020 Mar;80:106210. doi: 10.1016/j.intimp.2020.106210.
Ping Xin 1 Xiaoyun Xu 1 Chengjie Deng 1 Shuang Liu 1 Youzhi Wang 2 Xuegang Zhou 1 Hongxing Ma 3 Donghua Wei 1 Shiqin Sun 4
Affiliations

Affiliations

  • 1 College of Pharmacy, Harbin Medical University-Daqing, Daqing 163319, China.
  • 2 Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
  • 3 Clinical Laboratory Department, Najing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Najing 211200, China.
  • 4 College of Pharmacy, Harbin Medical University-Daqing, Daqing 163319, China. Electronic address: ssq7610@126.com.
Abstract

The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway and involved in many crucial biological processes, including cell proliferation, differentiation, Apoptosis, and immune regulation. It provides a direct mechanism for extracellular factors-regulated gene expression. Current researches on this pathway have been focusing on the inflammatory and neoplastic diseases and related drug. The mechanism of JAK/STAT signaling is relatively simple. However, the biological consequences of the pathway are complicated due to its crosstalk with other signaling pathways. In addition, there is increasing evidence indicates that the persistent activation of JAK/STAT signaling pathway is closely related to many immune and inflammatory diseases, yet the specific mechanism remains unclear. Therefore, it is necessary to study the detailed mechanisms of JAK/STAT signaling in disease formation to provide critical reference for clinical treatments of the diseases. In this review, we focus on the structure of JAKs and STATs, the JAK/STAT signaling pathway and its negative regulators, the associated diseases, and the JAK inhibitors for the clinical therapy.

Keywords

JAK/STAT pathway and diseases; JAK/STAT signaling pathway; JAKs inhibitors and diseases; Negative regulators.

Figures